2-(bicyclo[2.2.1]heptan-2-yl)-N-((S)-1-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-2,5-dioxopyrrolidin-3-yl)acetamide
2-(bicyclo[2.2.1]heptan-2-yl)-N-((S)-1-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-2,5-dioxopyrrolidin-3-yl)acetamide
SMILES |
COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC(C3=O)NC(=O)CC4CC5CCC4C5 |
InChIKey |
OYMUVIUADSJJGL-UHFFFAOYSA-N |
Chemical Properties
Hydrogen bond acceptors |
6 |
Hydrogen bond donors |
1 |
Rotatable bonds |
8 |
Molecular weight (Da) |
468.3 |
Bioactivities
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
2-(bicyclo[2.2.1]heptan-2-yl)-N-((S)-1-(2-(4-(2-methoxyphenyl)piperazin-1-yl)ethyl)-2,5-dioxopyrrolidin-3-yl)acetamide
Drug properties
Molecular type |
Small molecule |
Physiological/Surrogate |
Surrogate |
Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.